ALR2-IN-6

ALR2-IN-6 (compound 9) is a potent and competitive ALR2 inhibitor with a Ki of 0.064 μM. ALR2-IN-6 can be used in the study of neuropathy, retinopathy, and nephropathy[1].

Product Specifications

UNSPSC

12352005

Target

Aldose Reductase

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease; Neurological Disease

Smiles

O=C1N(/N=C/C2=CC=C(Br)C=C2F)C(C3CCCCC3)=NC4=C1C=CC=C4

Molecular Formula

C21H19BrFN3O

Molecular Weight

428.30

References & Citations

[1]Tokalı P, et al. Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4 (3H) -one derivatives with 4-Bromo-2-Fluorobenzene functionality. Bioorg Chem. 2025 May 19;162:108614.